Help us improve our site.
Classifying cancer-causing substances
Various international agencies follow a scientific process and consider the weight of scientific evidence to determine whether a substance or chemical causes cancer. They have different ways of describing how clear and strong the scientific evidence is, and how confident scientists are about the risk associated with exposure.
The World Health Organization, through its agency called IARC, uses 4 classes to describe its conclusions after reviewing the scientific evidence:
- Class 1: exposure causes cancer in humans
- Class 2A: exposure probably causes cancer in humans
- Class 2B: exposure possibly causes cancer in humans
- Class 3: scientists are unable to determine or classify whether exposure does or does not cause cancer in humans
- Class 4: exposure probably does not cause cancer in humans
IARC publishes its scientific evaluations of these substances in a series of in depth reports called monographs.
The NTP in the United States follows a similar process to describe whether a substance causes cancer in humans. Following the review of animal and human scientific information, NTP scientists classify substances as either:
- known to be human carcinogen
- reasonably anticipated to be human carcinogen
The NTP publish their classifications in the regularly updated Report on Carcinogens.
The United States EPA reviews pesticides and other toxic chemicals for likelihood that they cause cancer. Based on reviews of animal studies, it classifies substances in one of 5 categories:
- carcinogenic to humans
- likely to be carcinogenic to humans
- suggestive evidence of carcinogenic potential
- inadequate information to assess carcinogenic potential
- not likely to be carcinogenic to humans
Volunteering during Daffodil Month is an incredibly rewarding experience, whether you have been touched by cancer or not.
Advocating for cancer patients
Our staff and volunteers meet with elected officials from local, provincial and national governments to persuade them to make the fight against cancer one of their top priorities.